New gene signature predicts immunotherapy success for bone marrow cancers
A team led by researchers from the German Cancer Research Center (DKFZ), the HI-STEM Stem Cell Institute, and Medical…
Researchers find a new genetic vulnerability in acute myeloid leukemia
A study published in Nature Cell Biology reports a new vulnerability in acute myeloid leukemia (AML) that might…
Study explains how leukemia creates inflammatory lung environments
Acute myeloid leukemia (AML) does more than infiltrate the lungs: it also transforms lung tissue to create an…
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
Moleculin Biotech, Inc. Moleculin Biotech, Inc. INTERIM EFFICACY – N=45 INTENT TO TREAT (ITT) Both Annamycin dose arms…
Dr. Soheil Meshinchi, a leading expert in acute myeloid leukemia, named Dylan Burke Endowed Chair in Immunotherapy
As a child, Dylan Burke was an athlete and gymnast who shunned sugar and worked out every day, and a budding mad…
Timing of genetic mutation dictates childhood leukemia aggressiveness
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with…
Aza-ven shows superior outcomes compared to induction chemotherapy in AML patients
In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined…
Engineered Bone Marrow Model Advances CRISPR-CAR T Research in AML
Credit: Kateryna Kon/Science Photo Library/Getty Images Scientists at the University of Glasgow developed a bioengineered bone marrow (BM)…